Gene · 2017
Papers4,431
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,221 to 2,240 of 4,431
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Counterbalancing anti-adhesive effects of Tenascin-C through fibronectin expression in endothelial cells. | Sci Rep | 2017 | 28986537 | PubTator, text mining | PubMed |
| Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | Nat Commun | 2017 | 28986522 | PubTator, text mining | PubMed |
| Tyrosine dephosphorylated cortactin downregulates contractility at the epithelial zonula adherens through SRGAP1. | Nat Commun | 2017 | 28983097 | PubTator, text mining | PubMed |
| Lysosome trafficking is necessary for EGF-driven invasion and is regulated by p38 MAPK and Na+/H+ exchangers. | BMC Cancer | 2017 | 28978320 | PubTator, text mining | PubMed |
| The actin-related p41ARC subunit contributes to p21-activated kinase-1 (PAK1)-mediated glucose uptake into skeletal muscle cells. | J Biol Chem | 2017 | 28972183 | PubTator, text mining | PubMed |
| Effects of estrogen receptor modulators on cytoskeletal proteins in the central nervous system. | Neural Regen Res | 2017 | 28966632 | PubTator, text mining | PubMed |
| Nck deficiency is associated with delayed breast carcinoma progression and reduced metastasis. | Mol Biol Cell | 2017 | 28954862 | PubTator, text mining | PubMed |
| 5-Azacytidine promotes invadopodia formation and tumor metastasis through the upregulation of PI3K in ovarian cancer cells. | Oncotarget | 2017 | 28947962 | PubTator, text mining | PubMed |
| Cooperative but distinct early co-signaling events originate from ERBB2 and ERBB1 receptors upon trastuzumab treatment in breast cancer cells. | Oncotarget | 2017 | 28947957 | PubTator, text mining | PubMed |
| Podocalyxin-Like Protein 1 Regulates TAZ Signaling and Stemness Properties in Colon Cancer. | Int J Mol Sci | 2017 | 28946619 | PubTator, text mining | PubMed |
| VCA nanobodies target N-WASp to reduce invadopodium formation and functioning. | PLoS One | 2017 | 28938008 | PubTator, text mining | PubMed |
| Functional Role of Gonadotrope Plasticity and Network Organization. | Front Endocrinol (Lausanne) | 2017 | 28936197 | PubTator, text mining | PubMed |
Novel derivative of Paeonol, Paeononlsilatie sodium, alleviates behavioral damage and hippocampal dendritic injury in Alzheimer's disease concurrent with cofilin1/phosphorylated-cofilin1 and RAC1/CDC42 alterations in rats. | PLoS One | 2017 | 28934273 | PubTator, text mining | PubMed |
| The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing FAK. | Sci Signal | 2017 | 28928239 | PubTator, text mining | PubMed |
| A Novel Pak1/ATF2/miR-132 Signaling Axis Is Involved in the Hematogenous Metastasis of Gastric Cancer Cells. | Mol Ther Nucleic Acids | 2017 | 28918037 | PubTator, text mining | PubMed |
| MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma. | Oncotarget | 2017 | 28915663 | PubTator, text mining | PubMed |
| TDP-43/HDAC6 axis promoted tumor progression and regulated nutrient deprivation-induced autophagy in glioblastoma. | Oncotarget | 2017 | 28915616 | PubTator, text mining | PubMed |
| MPZL1 forms a signalling complex with GRB2 adaptor and PTPN11 phosphatase in HER2-positive breast cancer cells. | Sci Rep | 2017 | 28912526 | PubTator, text mining | PubMed |
| Human histone deacetylase 6 shows strong preference for tubulin dimers over assembled microtubules. | Sci Rep | 2017 | 28912522 | PubTator, text mining | PubMed |
| Using a Novel Microfabricated Model of the Alveolar-Capillary Barrier to Investigate the Effect of Matrix Structure on Atelectrauma. | Sci Rep | 2017 | 28912466 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2017/papers?page=112